MedTrace Logo

Brain Stimulation for Patients With Parkinson Disease

NCT04333511 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-10-03

No results posted yet for this study

Summary

The aim of this crossover study is to investigate the efficacy of non-invasive brain stimulation (transcranial pulse stimulation; TPS) in adults with Parkinson Disease (PD). Participants will receive 6 sessions of TPS and Sham-TPS, respectively, in random order. Motor manifestations of PD and manual dexterity will be the primary outcome measures. Outcomes will be assessed immediately post-treatment.

Conditions

  • Parkinson Disease

Interventions

DEVICE

TPS (NEUROLITH)

6 treatments of TPS over 2 weeks

DEVICE

Sham-TPS (NEUROLITH)

6 treatments of Sham-TPS over 2 weeks

Sponsors & Collaborators

  • Storz Medical AG

    lead INDUSTRY

Principal Investigators

  • Roland Beisteiner, Prof. · Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-02
Primary Completion
2022-08-03
Completion
2022-08-03

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04333511 on ClinicalTrials.gov